SEC Comment Letter 0000000000-24-009724 to Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)

Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: Aug. 26, 2024 · CIK: 0001130598 · Accession: 0000000000-24-009724

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-36020

Date

August 26, 2024

Author

Werner Cautreels

Form

UPLOAD

Company

Traws Pharma, Inc. (TRAW) (CIK 0001130598)

Letter

August 26, 2024 Werner Cautreels Chief Executive Officer Traws Pharma, Inc. 12 Penns Trail Newtown, PA 18940 Re:Traws Pharma, Inc. Preliminary Proxy Statement on Schedule 14A Filed June 27, 2024 File No. 001-36020 Dear Werner Cautreels: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Joanne R. Soslow

Show Raw Text

August 26, 2024
Werner Cautreels
Chief Executive Officer
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940
Re:Traws Pharma, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed June 27, 2024
File No. 001-36020
Dear Werner Cautreels:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Joanne R. Soslow

SecProbe.io